Two-Day Drug Regimen Enough to Control Severe Immune Disease After Some Bone Marrow Transplants - 10/7/14

Johns Hopkins and other cancer researchers report that a very short course of a chemotherapy drug, called cyclophosphamide, not only can prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate such patients’ need for the usual six months of immune suppression medicines commonly prescribed to prevent severe forms of this immune response.
Source: Johns Hopkins Medicine News - Category: Research Source Type: news